KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Inventory: 2016-2025

Historic Change in Inventory for Acadia Pharmaceuticals (ACAD) over the last 9 years, with Sep 2025 value amounting to -$1.2 million.

  • Acadia Pharmaceuticals' Change in Inventory fell 193.76% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 70.55%. This contributed to the annual value of $49.5 million for FY2024, which is 72.00% up from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Change in Inventory stood at -$1.2 million for Q3 2025, which was down 130.44% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Change in Inventory registered a high of $27.1 million during Q2 2024, and its lowest value of -$1.2 million during Q3 2025.
  • For the 3-year period, Acadia Pharmaceuticals' Change in Inventory averaged around $8.3 million, with its median value being $4.4 million (2024).
  • In the last 5 years, Acadia Pharmaceuticals' Change in Inventory slumped by 269.31% in 2022 and then soared by 4,960.32% in 2023.
  • Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Change in Inventory stood at -$217,000 in 2021, then plummeted by 42.86% to -$310,000 in 2022, then soared by 4,960.32% to $15.1 million in 2023, then slumped by 70.64% to $4.4 million in 2024, then plummeted by 193.76% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, $4.1 million for Q2 2025, and $10.5 million during Q1 2025.